SummaryBackground. Skin disorders are common in children in Ethiopia, and it is estimated that 92 000 Ethiopian children are infected with human immunodeficiency virus (HIV). HIV infection increases the prevalence of cutaneous disease, but the effect of antiretroviral therapy (ART) on the pattern of skin disease affecting children in subSaharan Africa (SSA) is unclear. Aim. To assess the prevalence and nature of skin disorders in HIV-infected children living in a dedicated orphanage in Addis Ababa, Ethiopia. Methods. Two dermatologists performed a clinical examination, including the skin, hair, nails and oral cavity of all the residents of an orphanage in Addis Ababa. The examiners knew that all the children were infected with HIV, but did not know their treatment or immune status. Diagnoses were made clinically and recorded anonymously, and treatment recommendations were made. Details of the children's treatment and CD4 lymphocyte counts were obtained after the examination had been completed. Results. In total, 84 children [53 male (63%); 31 female (37%); median age 10 years] were examined. Of the 84 children, 57 (68%) were on ART, with 51 (61%) of these on cotrimoxazole prophylaxis. The median CD4 percentage was 27.1%. There were 66 children (79%) with at least one skin disorder; 21 of these had two disorders and 6 had three disorders. The commonest diagnosis was tinea capitis, affecting 39% of children. The other common diagnoses were: molluscum contagiosum (MC) (21%), verruca vulgaris (13%), plane warts (8%) and seborrhoeic dermatitis (7%). There was no significant difference in the prevalence of skin disease between children receiving ART and those who were not. Children with MC had significantly lower recent CD4 counts than children who did not have skin disease. Conclusions. Skin disorders in this population were very common, and the disorders identified were those that commonly affect children without HIV in Ethiopia. However, MC and plane warts appeared to have a higher frequency than would be expected in uninfected children.
The human immunodeficiency virus (HIV) epidemic resulted in decreased fertility among HIV-positive women, who did not want to transmit the virus to their unborn children. With the availability of antiretroviral therapy that suppresses viral load, HIV-infected women live normal lives and even acknowledge the desire and intention to have children, a factor that is rarely acknowledged in antiretroviral therapy (ART) clinic services. This study examined fertility intentions and contraception use among a sample of women attending an ART clinic in Oromia Region, Ethiopia. Methods: A quantitative, cross-sectional and descriptive design was used on a sample of 362 HIV-positive women. Data were collected using a researcher-administered questionnaire. Results: The ages of the participants ranged from 18 to 49 years and most were between the ages of 23 and 32. A desire and intention to fall pregnant was reported by 46.6% (n = 158) of the participants. A total of 114 (35.5%) had given birth after they were diagnosed with HIV and 4% were pregnant at the time of the study. Of the study participants who wanted to have children, 60.7% (n = 82) planned to have a child within two years. In the period before they were diagnosed with HIV, most participants used injectable contraceptives but this changed to using the condom after they were diagnosed with HIV. Conclusion:The high number of women who have both the desire and intention to have children among this sample of HIVpositive women requires that reproductive health services need to include family planning as an essential component of reproductive health services. The change to using the condom as a contraceptive method indicates the positive impact of health promotion received at ART clinic.
Background: The human immunodeficiency virus (HIV) epidemic resulted in decreased fertility among HIV-positive women, who did not want to transmit the virus to their unborn children. With the availability of antiretroviral therapy that suppresses viral load, HIV-infected women live normal lives and even acknowledge the desire and intention to have children, a factor that is rarely acknowledged in antiretroviral therapy (ART) clinic services. This study examined fertility intentions and contraception use among a sample of women attending an ART clinic in Oromia Region, Ethiopia. Methods: A quantitative, cross-sectional and descriptive design was used on a sample of 362 HIV-positive women. Data were collected using a researcher-administered questionnaire. Results: The ages of the participants ranged from 18 to 49 years and most were between the ages of 23 and 32. A desire and intention to fall pregnant was reported by 46.6% (n = 158) of the participants. A total of 114 (35.5%) had given birth after they were diagnosed with HIV and 4% were pregnant at the time of the study. Of the study participants who wanted to have children, 60.7% (n = 82) planned to have a child within two years. In the period before they were diagnosed with HIV, most participants used injectable contraceptives but this changed to using the condom after they were diagnosed with HIV. Conclusion: The high number of women who have both the desire and intention to have children among this sample of HIV-positive women requires that reproductive health services need to include family planning as an essential component of reproductive health services. The change to using the condom as a contraceptive method indicates the positive impact of health promotion received at ART clinic. (Full text of the research articles are available online at www.medpharm.tandfonline.com/ojfp) S Afr Fam Pract 2017; DOI: 10.1080/20786190.2016.1254931
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.